为了进一步提高疗效，对２１２例原发性肝癌手术后生存５年以上病例进行了分析。其中Ⅰ期９７例、Ⅱ期１１５例，瘤体≤５ｃｍｌｌ５例。其中１１４例系小肝癌，７０例为非小肝癌，１６例系二期切除，１２例系切除以外的姑息性外科手术。再手术４４例，其中亚临床复发３８例、肺转移６例。至１９９４年１２月，随访期６１～３９７个月（平均１０９个月），生存１０年以上５７例，１５年以上２４例，２０年以上５例，最长１例无瘤生存已３３年。此外对提高肝癌切除后远期疗效进行了讨论。 In order to further improve the efficacy, 212 cases of primary liver cancer who survived after surgery for more than 5 years were analyzed. Of these, 97 were in phase I and 115 were in phase II. Five tumors ≤ 5 cmll. Among them, 114 cases were small hepatocellular carcinoma, 70 cases were non-small hepatocellular carcinoma, 16 cases were secondary resection, and 12 cases were palliative surgery other than resection. Of the 44 patients undergoing reoperation, 38 had subclinical recurrence and 6 had pulmonary metastases. By December 1994, the follow-up period was 61 to 397 months (mean 109 months), surviving more than 10 years in 57 cases, more than 15 years in 24 cases, more than 20 years in 5 cases, and the longest one had 33 years of tumor-free survival. In addition, the long-term curative effect of resection of hepatocellular carcinoma was discussed.